Delivering high quality medications developed specifically for pediatric patients

Welcome to Silvergate

WE ARE COMMITTED TO MAKING A DIFFERENCE IN THE LIVES OF PEDIATRIC PATIENTS

At Silvergate, we are dedicated to improving the quality, accessibility, and delivery of FDA-approved medications for children. Learn more about why we’re taking the lead in this critical area. Read More

Featured Product

Xatmep – The First and Only Ready-To-Use Methotrexate Oral Solution is Now Available
Click to view Prescribing information including Boxed Warning

Product News

FDA Approves Qbrelis™, the First and Only Lisinopril Oral Solution 1 mg/mL for Pediatric Patients 6 Years of Age and Older

Denver, July 29, 2016 — Silvergate Pharmaceuticals, Inc. (www.silvergatepharma.com), leader ...

Xatmep – The First and Only Ready-To-Use Methotrexate Oral Solution is Now Available

Denver, July 31, 2017 — Silvergate Pharmaceuticals, Inc. (www.silvergatepharma.com), leaders...

Qbrelis™, the First and Only Lisinopril Oral Solution 1 mg/mL for Pediatric Patients 6 Years of Age and Older, is Now Available

Denver, October 26, 2016 — Silvergate Pharmaceuticals, Inc. (www.silvergatepharma.com), lead...

FDA Approves Epaned, a Powder for a Liquid Form of Enalapril for Children and Adults

Silvergate Pharmaceuticals Inc. Enables Consistent Dosing For Children

Denver, 13 Aug...